ILF3 and non-small cell lung carcinoma: For example, lncRNA PTTG3P interacted with interleukin enhancer-binding factor 3 (ILF3) to stabilize the mRNAs of MAP2K6 and E2F1, which induced malignant transformation in the mouse model of NSCLC (Wang J. et al., 2023).